YLYingzhao Liu

Yingzhao Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yingzhao Liu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Huiyong Peng

    Department of Laboratory Medicine, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, China

    9 shared publications
  • Shengjun Wang

    Department of Laboratory Medicine, Jiangsu Province Engineering Research Center for Precise Diagnosis and Treatment of Inflammatory Diseases, The Affiliated Hospital of Jiangsu University, Zhenjiang, China

    6 shared publications
  • Jie Xing

    Department of Laboratory Medicine, Zhenjiang Medical School of Nanjing Medical University, Zhenjiang, Jiangsu 212002, China

    5 shared publications
  • Shengjun Wang

    Department of Laboratory Medicine, Jiangsu Province Engineering Research Center for Precise Diagnosis and Treatment of Inflammatory Diseases, The Affiliated Hospital of Jiangsu University, Zhenjiang, China

    5 shared publications
  • Huiyong Peng

    Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 2211166, China

    4 shared publications
  • Qian Xu

    Department of Endocrinology, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, China

    4 shared publications

Latest Publications

  • Open Access

    Exogenous insulin antibody syndrome presenting with concurrent hypoglycemia and hyperglycemia

    by Xiao-Po Wang, Yan Wu, Jing Wu, Ying-Zhao Liu, Hui Jiang

    Rationale: Antibodies against therapeutic insulin cause paradoxical hypoglycemia, termed exogenous insulin antibody syndrome (EIAS). This first report of glargine-induced EIAS post-total pancreatectomy introduces mycophenolate mofetil (MMF) as a novel steroid-sparing therapy. Patient Concerns: A 75-year-old woman developed refractory nocturnal hypoglycemia with daytime hyperglycemia (HbA1c 8.6%) 3 months post-pancreatectomy during glargine therapy. Diagnoses: Hypoglycemia (glucose 2.83 mmol/L) featured undetectable C-peptide, elevated insulin (103 μU/mL), high insulin autoantibodies (74.95 coi, Reference range 0–1.0), and polyethylene glycol (PEG) precipitation-confirmed antibody-bound insulin, with a marked decline in insulin concentration relative to baseline values (88% decline). Interventions: Standard approaches (switching to aspart insulin, carbohydrate enrichment, degludec/acarbose triple regimen) failed; prednisone alleviated hypoglycemia but provoked hyperglycemia. Outcomes: Mycophenolate mofetil (MMF) eliminated hypoglycemia within 2 weeks, reducing antibodies to 35.4 coi. Conclusion: This inaugural case highlights EIAS as a cause of unexplained hypoglycemia in pancreatectomized patients. MMF warrants consideration as primary immunosuppressive therapy for EIAS. Lessons: This case highlights that EIAS is a rare but important cause of paradoxical hypoglycemia and hyperglycemia in insulin-treated patients. MMF can serve as an effective therapeutic agent.

  • Open Access

    Long noncoding RNA FOXP1-DT modulates regulatory T cells in Graves’ disease

    by Qian Xu, Chuanbin Lu, Juan Xu, Mengli Zhou, Shanshan Li, Xianfang Shen, Shengjun Wang, Yingzhao Liu, Huiyong Peng

    Regulatory T cells (Tregs) are key contributors to maintaining immune system stability, and their impairment has been linked to the pathogenesis of Graves’ disease (GD). However, the precise molecular mechanisms driving Treg dysregulation in GD remain poorly understood. Our previous study identified a dysregulated long noncoding RNA, FOXP1-DT (forkhead box P1 divergent transcript), which might be related to Treg cells. This study aimed to investigate the role of FOXP1-DT in Tregs from individuals with GD. Fifteen patients diagnosed with GD and fifteen age- and sex-matched healthy controls were recruited. Our findings demonstrated that FOXP1-DT expression was markedly decreased in the peripheral blood mononuclear cells of GD patients and exhibited an inverse correlation with the concentration of thyroid-stimulating hormone receptor antibody. FOXP1-DT is mainly located in the nucleus and adjacent to the FOXP1 gene in the genome, a key transcription factor for Treg homeostasis. FOXP1 expression was also significantly reduced in GD patients and correlated positively with FOXP1-DT expression and Treg cell levels. Moreover, silencing FOXP1-DT reduced FOXP1 expression and Treg cell proportion, consistent with the clinical observation of a positive link between decreased FOXP1-DT expression and lower Treg frequency in GD patients. ROC curve analysis showed the potential biomarker value of FOXP1-DT in GD. These findings indicate that downregulated FOXP1-DT may be involved in the process of GD by regulating FOXP1-mediated Treg dyshomeostasis.

  • Open Access

    Recent advances of trace elements in autoimmune thyroid disease

    by Shanshan Li, Qian Xu, Shengjun Wang, Huiyong Peng, Yingzhao Liu

    Autoimmune thyroid disease (AITD), which includes Graves’ disease and Hashimoto’s thyroiditis, poses a substantial global health burden due to its strong environmental influences. Among environmental factors, trace elements are increasingly recognized for their dual roles in regulating thyroid physiology and immune function. This narrative review synthesizes current evidence on the roles of key trace elements-iodine, selenium, vitamin D, zinc, iron, copper, and magnesium-in AITD pathogenesis. We detail their essential functions in thyroid hormone synthesis and metabolism, and critically examine how imbalances (deficiency or excess) can disrupt immune homeostasis, thereby promoting autoimmunity via mechanisms like oxidative stress, aberrant immune cell differentiation, and loss of self-tolerance. This review highlights complex dose-response relationships, such as the U-shaped curve for iodine, and the protective roles of selenium and vitamin D through antioxidant and immunomodulatory pathways. For other elements, including zinc, iron, copper, and magnesium, emerging associations with AITD have been identified, but the mechanistic understanding remains limited. We conclude that imbalances in trace elements are pivotal environmental triggers for AITD. Future research should prioritize elucidating molecular mechanisms, investigating interactions among elements, and conducting long-term interventional studies to translate these findings into precise nutritional strategies for AITD prevention and management.


  • Open Access

    Expression profiling and bioinformatics analysis of serum exosomal circular RNAs in lymph node metastasis of papillary thyroid carcinoma

    by Huiyong Peng, Zhangwei Zhu, Jie Xing, Qian Xu, Changfeng Man, Shengjun Wang, Yingzhao Liu, Zhengdong Zhang

    Most papillary thyroid carcinoma (PTC) patients have a good prognosis, but lymph node metastasis (LNM) is the most common progressive manifestation and often leads to a poor-prognosis. However, few studies focused on the underlying mechanisms of LNM. This study aimed to identity the potential role of exosomal circRNAs that contribute to LNM in PTC. We found that 9000 aberrantly expressed exosomal circRNAs in PTC patients with LNM, including 684 observably upregulation and 2193 notably downregulation. Functional enrichment analyses indicated that these aberrantly expressed circRNAs were mainly enriched in a variety of molecules and signaling pathways related to the progression and LNM of PTC. Bioinformatics analysis screened 14 circRNA-miRNA-mRNA networks associated with LNM-related signaling pathways in PTC. Moreover, circTACC2-miR-7-EGFR and circBIRC6-miR-24-3p-BCL2L11 axes were verified for potential involvement in PTC with LNM. Additionally, 4 upregulated circRNAs-related hub genes and 8 hub genes associated with downregulated circRNAs were screened, some of which were involved in LNM of PTC through verification. Collectively, our data provided a novel framework for in-depth investigation of the function of dysregulated exosomal circRNAs and their potential biomarkers in PTC patients with LNM.


  • Open Access

    The role of the cGAS-STING pathway in metabolic diseases

    by Qian Xu, Jie Xing, Shengjun Wang, Huiyong Peng, Yingzhao Liu


  • Open Access

    Factors impacting the benefits and pathogenicity of Th17 cells in the tumor microenvironment

    by Jie Xing, Changfeng Man, Yingzhao Liu, Zhengdong Zhang, Huiyong Peng

    Tumor development is closely associated with a complex tumor microenvironment, which is composed of tumor cells, blood vessels, tumor stromal cells, infiltrating immune cells, and associated effector molecules. T helper type 17 (Th17) cells, which are a subset of CD4+ T cells and are renowned for their ability to combat bacterial and fungal infections and mediate inflammatory responses, exhibit context-dependent effector functions. Within the tumor microenvironment, different molecular signals regulate the proliferation, differentiation, metabolic reprogramming, and phenotypic conversion of Th17 cells. Consequently, Th17 cells exert dual effects on tumor progression and can promote or inhibit tumor growth. This review aimed to investigate the impact of various alterations in the tumor microenvironment on the antitumor and protumor effects of Th17 cells to provide valuable clues for the exploration of additional tumor immunotherapy strategies.


  • Open Access

    Circular RNA circNUP214 Modulates the T Helper 17 Cell Response in Patients With Rheumatoid Arthritis

    by Huiyong Peng, Jie Xing, Xuehua Wang, Xiangmei Ding, Xinyi Tang, Junli Zou, Shengjun Wang, Yingzhao Liu

    Circular RNAs (circRNAs) are important transcriptional regulators of genome expression that participate in the pathogenesis of human diseases. Mechanistically, circRNAs, as competitive endogenous RNAs (ceRNAs), can sponge microRNAs (miRNAs) with miRNA response elements. A previous study identified that hsa_circ_0089172 (circNUP214) is abnormally expressed in Hashimoto’s thyroiditis. However, the role of circNUP214 in rheumatoid arthritis (RA) remains unclear. In total, 28 RA patients and 28 healthy controls were enrolled in this study. We found that circNUP214 is an abundant and stable circRNA in RA patients that can potentially differentiate RA patients from healthy subjects. Additionally, the elevated levels of IL-23R positively correlated with circNUP214 expression. The knockdown of circNUP214 resulted in the reduction of IL-23R at both transcriptional and translational levels in human CD4+ T cells. The proportion of circulating Th17 cells and the transcript levels of IL-17A were increased in RA patients and were both positively correlated with IL-23R expression. Moreover, positive correlations between the transcript levels of circNUP214 and the percentage of Th17 cells and the transcript levels of IL-17A were observed in RA patients. The downregulation of circNUP214 decreased the proportion of Th17 cells and the transcript levels of IL-17A in vitro. Furthermore, circNUP214 functioned as a ceRNA for miR-125a-3p in RA patients. Taken together, our results indicate that elevated levels of circNUP214 contribute to the Th17 cell response in RA patients.


  • Open Access

    Comprehensive Analysis of lncRNA Expression Profile and the Potential Role of ENST00000604491 in Graves’ Disease

    by Yingzhao Liu, Junli Zou, Juan Xu, Xuehua Wang, Jie Xing, Li Wang, Huiyong Peng

    Background. Graves’ disease (GD) is one of the most common autoimmune diseases worldwide and develops in 20 to 50 cases per 100,000 persons annually. Long noncoding RNAs (lncRNAs) are widely expressed in multiple human diseases and have pivotal functions in gene regulation. This study is aimed at determining the lncRNA profile in peripheral blood mononuclear cells (PBMCs) from GD patients and investigating the role of ENST00000604491 in GD. Methods. A total of 31 GD patients and 32 normal controls were enrolled in the study. Next-generation sequencing was performed to identify the dysregulated lncRNAs in the PBMCs from the 5 GD patients and 5 normal controls, and 26 GD patients and 27 controls were used to verify the selected lncRNAs. The relative expression of verified lncRNAs, forkhead box P1 (FOXP1), and IKAROS family zinc finger 3 (IKZF3) from these samples was detected by quantitative real-time PCR. The potential biomarker value was assessed by using receiver operating characteristic (ROC) curve analysis. Results. A total of 37,683 dysregulated expressed lncRNAs were indicated, of which 5 lncRNAs were significantly upregulated and 83 lncRNAs were remarkably downregulated in the GD patients compared with healthy subjects. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses showed that abnormally expressed lncRNAs were mainly enriched in immune system-related signalling pathways. Among the selected lncRNAs, the relative expression of ENST00000604491 was significantly downregulated and negatively correlated with the serum levels of thyroid-stimulating hormone receptor antibodies (TRAb) in GD patients. Further studies confirmed that decreased FOXP1 expression was inversely correlated with serum TRAb levels in GD patients. Moreover, there was a notably positive correlation between ENST00000604491 expression and FOXP1 transcript levels in GD. The area under the ROC curve of ENST00000604491 was up to 0.74 (95% confidence interval: 0.60-0.87, ), and the sensitivity and specificity were 53.85% and 88.89%, respectively. Conclusion. The present study identifies ENST00000604491 as a significantly attenuated lncRNA in GD patients, which may contribute to the pathogenesis of GD by regulating FOXP1 and represent a potential biomarker for GD.


  • Open Access

    Elevated Expression of the Long Noncoding RNA MAFTRR in Patients with Hashimoto’s Thyroiditis

    by Huiyong Peng, Xiangmei Ding, Juan Xu, Yue Han, Jun Yang, Xinyi Tang, Shengjun Wang, Yingzhao Liu

    Background. Long noncoding RNAs (lncRNAs) represent an important novel class of noncoding RNA molecule greater than 200 nucleotides that play a key role in the regulation of autoimmune diseases. Previous studies have demonstrated that MAFTRR (MAF transcriptional regulator RNA) regulated Th1 cells differentiation by inhibiting the expression of MAF in activated CD4+ T cells. However, the effect of MAFTRR on the pathogenesis of Hashimotos thyroiditis (HT) remains unclear. This research was aimed at investigating the expression of MAFTRR in Hashimotos thyroiditis (HT) as well as the correlation between MAFTRR and Th1 cells. Methods. Thirty-eight HT patients and thirty-eight healthy controls were enrolled in the study. The proportion of Th1 cells and CD8+IFN-γ+ T cells in peripheral blood mononuclear cells (PBMCs) from these specimens was determined by flow cytometric analysis. The transcript levels of MAFTRR, MAF, and IFNG in PBMCs and thyroid glands were detected by quantitative real-time PCR. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the potential value of MAFTRR in the HT patients. Results. We found that the proportion of circulating Th1 cells and the transcript levels of IFNG were increased in peripheral blood of the HT patients. The transcript levels of MAFTRR were significantly increased in the HT patients and positively correlated with the percentage of Th1 cells and serum levels of antithyroglobulin antibody and antithyroperoxidase antibody. The transcript levels of MAF, a transcription factor that inhibits Th1 cells activity and IFN-γ production, were attenuated in PBMCs from the HT patients. The transcript levels of IFNG had positive and inverse correlations with MAFTRR and MAF expression in PBMCs from the HT patients, respectively. Additionally, a significantly positive correlation between upregulated MAFTRR expression and augmented IFNG expression was revealed in thyroid tissues from the HT patients. ROC curve suggested that MAFTRR could potentially differentiate the HT patients from healthy controls. Conclusion. MAFTRR is significantly augmented in the HT patients and may contribute to the pathogenic role of the Th1 cells response in HT.


  • Open Access

    The Roles of Exosomes in Immunoregulation and Autoimmune Thyroid Diseases

    by Junli Zou, Huiyong Peng, Yingzhao Liu

    Exosomes are extracellular microvesicles (30-150 nm) released from cells that contain proteins, lipids, RNA and DNA. They can deliver bioactive molecules and serve as carriers facilitating cell-cell communication, such as antigen presentation, inflammatory activation, autoimmune diseases (AIDs) and tumor metastasis. Recently, much attention has been attracted to the biology and functions of exosomes in immune regulation and AIDs, including autoimmune thyroid diseases (AITDs). Some studies have shown that exosomes are involved in the occurrence and development of AITDs, but they are still in the preliminary stage of exploration. This review mainly introduces the association of exosomes with immune regulation and emphasizes the potential role of exosomes in AITDs, aiming to provide new research strategies and directions for the pathogenesis and early diagnosis of AITDs.